What is this study trying to find out about Interstitial Lung Disease?

This study aims to understand the natural progression of Interstitial Lung Disease by collecting data and blood samples from patients and healthy controls. Researchers want to describe how the disease appears and changes over time. The study is led by the University of Chicago to improve knowledge of these lung conditions.

Who may be eligible for this Interstitial Lung Disease clinical trial?

Adults aged 18 years or older who have been diagnosed with Interstitial Lung Disease may be eligible. Participants of all genders can join. Key factors include having the disease and willingness to provide blood samples. Please review eligibility criteria for more details.

Is there any cost to participate in this Interstitial Lung Disease clinical trial?

Study-related care, including data collection and blood sampling, is provided at no cost. However, personal travel or other expenses may not be covered and can vary. Participants should consider these costs when planning to join the trial.

Actively Recruiting

Age: 18Years +

All Genders

Healthy Volunteers

ID00470327

Observational Study on the Natural Course of Interstitial Lung Disease and Related Conditions

Led by University of Chicago · Updated on 2026-06-09

4000

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying the natural progression of Interstitial Lung Disease ILD and related conditions such as Idiopathic Pulmonary Fibrosis, Sarcoidosis, and Connective Tissue Disorder. The goal is to collect detailed data and blood samples from patients receiving care in the ILD program as well as from a control group to better understand the different ways these diseases can appear and progress over time. Participants in this observational study will not receive a specific treatment but will contribute data and blood samples over time. This approach allows researchers to compare disease characteristics in affected patients with those in healthy controls, aiming to describe the phenotypic expression of these lung diseases. Throughout the study, participants will have yearly evaluations to track the natural history of their lung disease. Data collection will include clinical assessments and blood samples to monitor disease progression. The study is ongoing, with participation potentially lasting for many years, allowing for long-term observation of the disease course.

CONDITIONS

Brief Title

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

Who Can Participate

Age: 18Years +

All Genders

Healthy Volunteers

Eligibility Criteria

You may qualify if you...

Adults aged 18 years or older
Diagnosed with Interstitial Lung Disease

You will not qualify if you...

Does not have Interstitial Lung Disease

Research Team

Vanita Patel, MPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here